These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776 [TBL] [Abstract][Full Text] [Related]
4. Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular degeneration. Arnold J; Algan M; Soubrane G; Coscas G; Barreau E Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):208-16. PubMed ID: 9143888 [TBL] [Abstract][Full Text] [Related]
5. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Bressler NM; Maguire MG; Murphy PL; Alexander J; Margherio R; Schachat AP; Fine SL; Stevens TS; Bressler SB Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group. Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004 [TBL] [Abstract][Full Text] [Related]
7. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078 [TBL] [Abstract][Full Text] [Related]
8. Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group. Willan AR; Cruess AF; Ballantyne M Can J Ophthalmol; 1996 Feb; 31(1):11-7. PubMed ID: 8925479 [TBL] [Abstract][Full Text] [Related]
9. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol; 1994 Apr; 112(4):489-99. PubMed ID: 7512335 [TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol; 1993 Sep; 111(9):1189-99. PubMed ID: 7689826 [TBL] [Abstract][Full Text] [Related]
11. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Atebara NH; Thomas MA; Holekamp NM; Mandell BA; Del Priore LV Ophthalmology; 1998 Sep; 105(9):1598-605. PubMed ID: 9754163 [TBL] [Abstract][Full Text] [Related]
12. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol; 1993 Sep; 111(9):1200-9. PubMed ID: 7689827 [TBL] [Abstract][Full Text] [Related]
13. Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. The Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology; 1998 Aug; 105(8):1364-72. PubMed ID: 9709744 [TBL] [Abstract][Full Text] [Related]
14. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group. Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993 [TBL] [Abstract][Full Text] [Related]
15. Recurrent choroidal neovascularization after laser photocoagulation in Sorsby's fundus dystrophy. Holz FG; Haimovici R; Wagner DG; Bird AC Retina; 1994; 14(4):329-34. PubMed ID: 7529420 [TBL] [Abstract][Full Text] [Related]
16. A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients. Lanchoney DM; Maguire MG; Fine SL Arch Ophthalmol; 1998 Aug; 116(8):1045-52. PubMed ID: 9715685 [TBL] [Abstract][Full Text] [Related]